{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:32:07Z","timestamp":1773145927213,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T00:00:00Z","timestamp":1112227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T00:00:00Z","timestamp":1112227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.leu.2403733","type":"journal-article","created":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T10:52:48Z","timestamp":1112266368000},"page":"945-952","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma"],"prefix":"10.1038","volume":"19","author":[{"given":"G W","family":"van Imhoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"van der Holt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P W","family":"Wijermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H H","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M B","family":"van 't Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H C","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"van Marwijk Kooy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H J","family":"van Oers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M M","family":"Raemaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Sonneveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L A M H","family":"Meulendijks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P M","family":"Kluin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H C","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L F","family":"Verdonck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,31]]},"reference":[{"key":"BF2403733_CR1","volume-title":"World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. IARC WHO Classification of Tumours, (ed)","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. IARC WHO Classification of Tumours, (ed). Lyon: IARC Press, 2001."},{"key":"BF2403733_CR2","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood.V63.5.1102.1102","volume":"63","author":"IT Magrath","year":"1984","unstructured":"Magrath IT, Janus C, Edwards BK, Spiegel R, Jaffe ES, Berard CW et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102\u20131111.","journal-title":"Blood"},{"key":"BF2403733_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1200\/JCO.1996.14.4.1252","volume":"14","author":"WP Bowman","year":"1996","unstructured":"Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. J Clin Oncol 1996; 14: 1252\u20131261.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR4","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","volume":"97","author":"C Patte","year":"2001","unstructured":"Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D et al. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001; 97: 3370\u20133379.","journal-title":"Blood"},{"key":"BF2403733_CR5","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","volume":"4","author":"SB Murphy","year":"1986","unstructured":"Murphy SB, Bowman WP, Abromowitch M, Mirro J, Ochs J, Rivera G et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986; 4: 1732\u20131739.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","volume":"13","author":"A Reiter","year":"1995","unstructured":"Reiter A, Schrappe M, Parwaresch R, Henze G, Muller-Weihrich S, Sauter S et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage \u2013 a report of the Berlin\u2013Frankfurt\u2013Munster Group. J Clin Oncol 1995; 13: 359\u2013372.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR7","doi-asserted-by":"crossref","unstructured":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"BF2403733_CR8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","volume":"85","author":"C Soussain","year":"1995","unstructured":"Soussain C, Patte C, Ostronoff M, Delmer A, Rigal-Huguet F, Cambier N et al. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 1995; 85: 664\u2013674.","journal-title":"Blood"},{"key":"BF2403733_CR9","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","volume":"14","author":"I Magrath","year":"1996","unstructured":"Magrath I, Adde M, Shad A, Venzon D, Seibel N, Gootenberg J et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14: 925\u2013934.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E, Gassmann W, Loffler H, Fonatsch C et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495\u2013508.","journal-title":"Blood"},{"key":"BF2403733_CR11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","volume":"17","author":"DA Thomas","year":"1999","unstructured":"Thomas DA, Cortes J, O'Brien S, Pierce S, Faderl S, Albitar M et al. Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. J Clin Oncol 1999; 17: 2461\u20132470.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR12","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1200\/JCO.2001.19.20.4014","volume":"19","author":"EJ Lee","year":"2001","unstructured":"Lee EJ, Petroni GR, Schiffer CA, Freter CE, Johnson JL, Barcos M et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol 2001; 19: 4014\u20134022.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V61.1.92.92","volume":"61","author":"AM Levine","year":"1983","unstructured":"Levine AM, Forman SJ, Meyer PR, Koehler SC, Liebman H, Paganini-Hill A et al. Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood 1983; 61: 92\u201398.","journal-title":"Blood"},{"key":"BF2403733_CR14","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","volume":"4","author":"CN Coleman","year":"1986","unstructured":"Coleman CN, Picozzi Jr VJ, Cox RS, McWhirter K, Weiss LM, Cohen JR et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 1986; 4: 1628\u20131637.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1200\/JCO.1986.4.1.57","volume":"4","author":"DE Slater","year":"1986","unstructured":"Slater DE, Mertelsmann R, Koziner B, Higgins C, McKenzie S, Schauer P et al. Lymphoblastic lymphoma in adults. J Clin Oncol 1986; 4: 57\u201367.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR16","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002; 99: 4379\u20134385.","journal-title":"Blood"},{"key":"BF2403733_CR17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V80.5.1130.1130","volume":"80","author":"A Nademanee","year":"1992","unstructured":"Nademanee A, Schmidt GM, O'Donnell MR, Snyder DS, Parker PA, Stein A et al. High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study [see comments]. Blood 1992; 80: 1130\u20131134.","journal-title":"Blood"},{"key":"BF2403733_CR18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1200\/JCO.1993.11.5.931","volume":"11","author":"AS Freedman","year":"1993","unstructured":"Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC et al. Autologous bone marrow trans-plantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. J Clin Oncol 1993; 11: 931\u2013936.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, de Gast GC, Lokhorst HM, Nieuwenhuis HK . Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 1992; 10: 644\u2013646.","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"BF2403733_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/annonc\/2.suppl_2.181","volume":"2","author":"G Santini","year":"1991","unstructured":"Santini G, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A et al. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG). Ann Oncol 1991; 2 (Suppl 2): 181\u2013185.","journal-title":"Ann Oncol"},{"key":"BF2403733_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","volume":"73","author":"N Milpied","year":"1989","unstructured":"Milpied N, Ifrah N, Kuentz M, Maraninchi D, Colombat P, Blaise D et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989; 73: 82\u201387.","journal-title":"Br J Haematol"},{"key":"BF2403733_CR22","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","volume":"12","author":"JW Sweetenham","year":"1994","unstructured":"Sweetenham JW, Liberti G, Pearce R, Taghipour G, Santini G, Goldstone AH . High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation. J Clin Oncol 1994; 12: 1358\u20131365.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR23","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","volume":"13","author":"GM Mead","year":"2002","unstructured":"Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Norbert P et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 2002; 13: 1264\u20131274.","journal-title":"Ann Oncol"},{"key":"BF2403733_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/1042819031000141301","volume":"45","author":"A Lacasce","year":"2004","unstructured":"Lacasce A, Howard O, Lib S, Fisher D, Weng A, Neuberg D et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma 2004; 45: 761\u2013767.","journal-title":"Leuk Lymphoma"},{"key":"BF2403733_CR25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361\u20131392.","journal-title":"Blood"},{"key":"BF2403733_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20009","volume":"40","author":"E Haralambieva","year":"2004","unstructured":"Haralambieva E, Schuuring E, Rosati S, van Noesel C, Jansen P, Appel I et al. Interphase fluorescence in situ hybridization for detection of MYC\/8q24 breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions. Genes Chromosomes Cancer 2004; 40: 10\u201318.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403733_CR27","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244\u20131253.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR28","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"BF2403733_CR29","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1182\/blood.V97.12.3713","volume":"97","author":"RM Braziel","year":"2001","unstructured":"Braziel RM, Arber DA, Slovak ML, Gulley ML, Spier C, Kjeldsberg C et al. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features. Blood 2001; 97: 3713\u20133720.","journal-title":"Blood"},{"key":"BF2403733_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/10428190310001593120","volume":"45","author":"WY Au","year":"2004","unstructured":"Au WY, Horsman DE, Gascoyne RD, Viswanatha DS, Klasa RJ, Connors JM . The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma 2004; 45: 519\u2013528.","journal-title":"Leuk Lymphoma"},{"key":"BF2403733_CR31","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB . Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 1980; 7: 332\u2013339.","journal-title":"Semin Oncol"},{"key":"BF2403733_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","volume":"4","author":"JI Bernstein","year":"1986","unstructured":"Bernstein JI, Coleman CN, Strickler JG, Dorfman RF, Rosenberg SA . Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 1986; 4: 847\u2013858.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1200\/JCO.1990.8.4.615","volume":"8","author":"TM Lopez","year":"1990","unstructured":"Lopez TM, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F, Redman JR et al. Small noncleaved cell lymphoma in adults: superior results for stages I-III disease. J Clin Oncol 1990; 8: 615\u2013622.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1200\/JCO.1991.9.6.941","volume":"9","author":"ML McMaster","year":"1991","unstructured":"McMaster ML, Greer JP, Greco FA, Johnson DH, Wolff SN, Hainsworth JD . Effective treatment of small-noncleaved-cell lymphoma with high-intensity, brief-duration chemotherapy. J Clin Oncol 1991; 9: 941\u2013946.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR35","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1200\/JCO.1994.12.10.2153","volume":"12","author":"DL Longo","year":"1994","unstructured":"Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI et al. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy. J Clin Oncol 1994; 12: 2153\u20132159.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR36","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.1996.14.1.240","volume":"14","author":"M Divine","year":"1996","unstructured":"Divine M, Lepage E, Briere J, Pautier P, Dupriez B, Lederlin P et al. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 1996; 14: 240\u2013248.","journal-title":"J Clin Oncol"},{"key":"BF2403733_CR37","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2141.2004.05141.x","volume":"126","author":"MD Nicola","year":"2004","unstructured":"Nicola MD, Carlo-Stella C, Mariotti J, Devizzi L, Massimino M, Cabras A et al. High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults. Br J Haematol 2004; 126: 815\u2013820.","journal-title":"Br J Haematol"},{"key":"BF2403733_CR38","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 2000; 95: 416\u2013421.","journal-title":"Blood"},{"key":"BF2403733_CR39","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1038\/sj.leu.2403095","volume":"17","author":"S Le Gouill","year":"2003","unstructured":"Le Gouill S, Lepretre S, Briere J, Morel P, Bouabdallah R, Raffoux E et al. Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87\/93 trials. Leukemia 2003; 17: 2220\u20132224.","journal-title":"Leukemia"},{"key":"BF2403733_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2141.1998.00559.x","volume":"100","author":"S Daenen","year":"1998","unstructured":"Daenen S, van Imhoff GW, van den Berg E, de Kam PJ, Haaxma-Reiche H, Vellenga E et al. Improved outcome of adult acute lymphoblastic leukaemia by moderately intensified chemotherapy which includes a \u2018pre-induction\u2019 course for rapid tumour reduction: preliminary results on 66 patients. Br J Haematol 1998; 100: 273\u2013282.","journal-title":"Br J Haematol"},{"key":"BF2403733_CR41","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"JW Sweetenham","year":"2001","unstructured":"Sweetenham JW, Santini G, Qian W, Guelfi M, Schmitz N, Simnett S et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation\/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927\u20132936.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403733","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:32:06Z","timestamp":1648776726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,31]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF2403733"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403733","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,31]]},"assertion":[{"value":"14 December 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}